Compare GERN & DNUT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GERN | DNUT |
|---|---|---|
| Founded | 1990 | 1937 |
| Country | United States | United States |
| Employees | N/A | 22800 |
| Industry | Biotechnology: Pharmaceutical Preparations | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 753.3M | 660.4M |
| IPO Year | 1996 | 2021 |
| Metric | GERN | DNUT |
|---|---|---|
| Price | $1.30 | $3.71 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 6 |
| Target Price | $3.00 | ★ $6.22 |
| AVG Volume (30 Days) | ★ 7.7M | 2.3M |
| Earning Date | 02-25-2026 | 02-24-2026 |
| Dividend Yield | N/A | ★ 1.82% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $183,403,000.00 | ★ $1,534,272,000.00 |
| Revenue This Year | $147.42 | N/A |
| Revenue Next Year | $37.07 | $0.77 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 522.13 | N/A |
| 52 Week Low | $1.04 | $2.50 |
| 52 Week High | $3.12 | $9.56 |
| Indicator | GERN | DNUT |
|---|---|---|
| Relative Strength Index (RSI) | 47.74 | 36.12 |
| Support Level | $1.28 | $4.12 |
| Resistance Level | $1.48 | $4.49 |
| Average True Range (ATR) | 0.07 | 0.22 |
| MACD | -0.01 | -0.06 |
| Stochastic Oscillator | 9.37 | 2.38 |
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
Krispy Kreme Inc is a sweet treat brand company. The company's Original Glazed doughnut is recognized for its hot-off-the-line, melt-in-your-mouth experience. It operates through its network of fresh Doughnut Shops, partnerships with retailers, and a growing e-commerce and delivery business. The company conducts its business through the following three reported segments: U.S., which includes all operations in the United States; International, which includes operations in the U.K., Ireland, Australia, New Zealand, Canada, Japan, and Mexico; and Market Development, which includes franchise operations across the globe. It derives maximum revenue from the U.S. segment.